People with Parkinson's (PwP) have depleted levels of dopamine in the brain. From the 1970s, levodopa, which is metabolised to dopamine, was utilised to treat the disabling motor symptoms. Initially...
There have been numerous studies and articles over the last few years looking at deprescribing in mental health. For example, Bjerre et al (2018) outline that the deprescribing of antipsychotics for...
Severe hypoglycaemia is the second most common cause of hospital admission for drug-related adverse events (Robson, 2017). Acute episodes of hypoglycaemia (generally defined as a blood glucose level...
There are a number of definitions of the term deprescribing. At its core are facets of the medicines optimisation movement and concerns about polypharmacy, particularly in older adult care..
Symptoms are experienced by around 70-80% of women during the perimenopause and menopause (O’Neill and Eden, 2012). The symptoms are varied and include vasomotor symptoms, such as flushing and night...
Awareness of the anatomical changes that occur during the end stages of life is fundamental to supporting the rationale for stopping medications (Mangoni and Jackson, 2003). When a disease progresses,...
Shared decision-making, a key component of universal personalised care in The NHS Long Term Plan (NHS, 2019), aims to provide people with the same choice and control over their mental and physical...
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills